LINC01206: A Potential Drug Target and Biomarker (G100996490)

Target Name: LINC01206

NCBI ID: G100996490

LINC01206

Other Name(s): Long intergenic non-protein coding RNA 1206 | long intergenic non-protein coding RNA 1206

LINC01206: A Potential Drug Target and Biomarker

LINC01206 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the defining features of LINC01206 is its unique structure. It consists of a long N-terminus, a middle transmembrane region, and a C-terminus that includes a unique farnesylated cysteine residue. This cysteine residue is unique because it is not typically found in proteins that are involved in cell adhesion, and its presence suggests that LINC01206 has a unique function.

In addition to its unique structure, LINC01206 has been shown to play a number of important roles in various biological processes. For example, it has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs. It has also been shown to play a role in the regulation of the immune system, which is important for protecting the body against infection and disease.

One of the most promising aspects of LINC01206 is its potential as a drug target. Because it is involved in so many important biological processes, it is a promising target for a variety of drugs. For example, drugs that can modulate the activity of LINC01206 have been shown to be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, LINC01206 is also a promising biomarker for a variety of diseases. Its unique structure and the functions it is involved in suggest that it may be an important indicator of the health of certain tissues and organs. For example, LINC01206 has been shown to be involved in the regulation of cell adhesion, which is a critical factor in the development and maintenance of tissues such as the brain and the heart. This suggests that LINC01206 may be an important biomarker for these diseases.

Overall, LINC01206 is a protein that has the potential to be a drug target and a biomarker for a variety of diseases. Its unique structure and the functions it is involved in suggest that it is an important player in various biological processes, and its potential as a drug target and biomarker make it an attractive target for research and development.

Protein Name: Long Intergenic Non-protein Coding RNA 1206

The "LINC01206 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01206 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets